Albert Batalla, MD, PhD

Department of Psychiatry, University Medical Center Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands

  • 2Articles
  • 3KReads
  • 2025–2026Active
  • 12Collaborators

About

Albert Batalla, MD, PhD, is affiliated with the Department of Psychiatry at the University Medical Center Utrecht Brain Center in The Netherlands. Batalla has published research focusing on addiction, specifically placebo effects in alcohol, cocaine, and methamphetamine use disorders, as well as treatment approaches for catatonia using (es)ketamine. Collaborations include work with Jan W. Schoones, Pim B. van der Meer, Annemieke Dols, Arjen J.C. Slooter, and Arnt Schellekens. Batalla's contributions appeared in Psychiatrist.com between 2025 and 2026.

Publications

JCP
Placebo Effects in Alcohol, Cocaine, and Methamphetamine Use Disorder
Meta-Analysis

Placebo Effects in Alcohol, Cocaine, and Methamphetamine Use Disorder

June 10, 2026

Placebo treatment led to reductions in craving scores across all three disorders, although statistical significance was achieved only in alcohol use disorder.
, , , et al
JCP
Treatment with (Es)ketamine in Catatonia: A Systematic Review of Case Reports
Brief Report

Treatment with (Es)ketamine in Catatonia: A Systematic Review of Case Reports

October 13, 2025

Recent evidence suggests that NMDA receptor antagonists, such as ketamine, may offer benefit in catatonia. This systematic review was conducted to evaluate the efficacy and safety of ketamine and...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe